» Articles » PMID: 12530981

Virus Subversion of the MHC Class I Peptide-loading Complex

Overview
Journal Immunity
Publisher Cell Press
Date 2003 Jan 18
PMID 12530981
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Many viral proteins modulate class I expression, yet, in general, their mechanisms of specific class I recognition are poorly understood. The mK3 protein of gamma(2)-Herpesvirus 68 targets the degradation of nascent class I molecules via the ubiquitin/proteasome pathway. Here, we identify cellular components of the MHC class I assembly machinery, TAP and tapasin, that are required for mK3 function. mK3 failed to regulate class I in TAP- or tapasin-deficient cells, and mK3 interacted with TAP/tapasin, even in the absence of class I. Expression of mK3 resulted in the ubiquitination of TAP/tapasin-associated class I, and mutants of class I incapable of TAP/tapasin interaction were unaffected by mK3. Thus, mK3 subverts TAP/tapasin to specifically target class I molecules for destruction.

Citing Articles

Shared pathway of WDFY4-dependent cross-presentation of immune complexes by cDC1 and cDC2.

Jo S, Ohara R, Theisen D, Kim S, Liu T, Bullock C J Exp Med. 2025; 222(4).

PMID: 39918736 PMC: 11804880. DOI: 10.1084/jem.20240955.


Mechanisms of substrate processing during ER-associated protein degradation.

Christianson J, Jarosch E, Sommer T Nat Rev Mol Cell Biol. 2023; 24(11):777-796.

PMID: 37528230 DOI: 10.1038/s41580-023-00633-8.


Mechanisms of CD40-dependent cDC1 licensing beyond costimulation.

Wu R, Ohara R, Jo S, Liu T, Ferris S, Ou F Nat Immunol. 2022; 23(11):1536-1550.

PMID: 36271147 PMC: 9896965. DOI: 10.1038/s41590-022-01324-w.


cDC1 Vaccines Drive Tumor Rejection by Direct Presentation Independently of Host cDC1.

Ferris S, Ohara R, Ou F, Wu R, Huang X, Kim S Cancer Immunol Res. 2022; 10(8):920-931.

PMID: 35648641 PMC: 9357132. DOI: 10.1158/2326-6066.CIR-21-0865.


Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation.

Li L, Zhang X, Wang X, Kim S, Herndon J, Becker-Hapak M Genome Med. 2021; 13(1):56.

PMID: 33879241 PMC: 8059244. DOI: 10.1186/s13073-021-00872-4.